Wound Treatments in the United Kingdom

Summary

This Wound Treatments in the UK report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2000-2005), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2010 illustrate how the market is set to change.

Product coverage: sticking plasters, other wound treatments Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

• Get a detailed picture of the wound treatments industry
• Identify growth sectors and factors driving change
• Understand the competitive environment, the market's major players and leading brands
• Use five-year forecasts to assess how the market is predicted to develop

Contents

• 1. Executive Summary
• 2. Operating Environment
  • 2.1 Otc Registration and Classification
  • 2.2 Vitamins and Dietary Supplements Registration and Classification
  • 2.3 Advertising
  • 2.4 Packaging and Labelling
  • 2.5 Distribution
  • 2.6 De-Listing or De-Reimbursement
  • 2.7 Traditional Remedies
  • 2.8 Homoeopathy
  • 2.9 Generics
  • 2.10 Consumer Expenditure on Health Goods and Medical Services
  • 2.11 Life Expectancy
• 3. Otc Healthcare Sales
  • 3.1 Market Performance
  • 3.2 Switches
  • 3.3 Key Trends and Developments
  • 3.4 Competitive Environment
  • 3.5 Leading Company Profile: Bayer Plc
  • 3.6 Leading Company Profile: Boots Healthcare International
  • 3.7 Leading Company Profile: Glaxosmithkline Plc
  • 3.8 Leading Company Profile: Johnson & Johnson Msd Ltd
  • 3.9 Leading Company Profile: Novartis Pharmaceuticals UK Ltd
  • 3.10 Leading Company Profile: Pfizer Consumer Healthcare Ltd
  • 3.11 Leading Company Profile: Reckitt Benckiser Plc
  • 3.12 Leading Company Profile: Roche Products Ltd
  • 3.13 Leading Company Profile: Seven Seas Ltd
  • 3.14 Leading Company Profile: Ssl International Plc
  • 3.15 Leading Company Profile: Wyeth Consumer Healthcare
  • 3.16 Emerging and Niche Companies
  • 3.17 Retail Distribution
  • 3.18 Retailer Activity and Private Label Trends
  • 3.19 Forecast Market Performance
• 4. Wound Treatments Sales
  • 4.1 Sector Performance
• 5.Definitions
• List of Summaries
  • Summary 1 Otc Healthcare Switches 2004-2005
  • Summary 2 Bayer Plc: Operational Indicators 2004
  • Summary 3 Boots Healthcare International: Operational Indicators 2005
  • Summary 4 Glaxosmithkline Plc: Operational Indicators 2005
  • Summary 5 Johnson & Johnson Msd Ltd: Operational Indicators 2004
  • Summary 6 Novartis Ag: Operational Indicators 2004
  • Summary 7 Pfizer Inc: Operational Indicators 2004
  • Summary 8 Reckitt Benckiser Plc: Operational Indicators 2004
  • Summary 9 Roche Products Ltd: Operational Indicators 2004
  • Summary 10 Seven Seas Ltd: Operational Indicators 2004
  • Summary 11 Ssl International Plc: Operational Indicators 2005
  • Summary 12 Wyeth Consumer Healthcare: Operational Indicators 2005
• List of Tables
  • Table 1 Retail Sales of Homoeopathy 1998-2005
  • Table 2 Consumer Expenditure on Health Goods and Medical Services 2000-2005
  • Table 3 Life Expectancy at Birth 2000-2005
  • Table 4 Sales of Otc Healthcare by Sector: Value 2000-2005
  • Table 5 Sales of Otc Healthcare by Sector: % Value Growth 2000-2005
  • Table 6 Otc Healthcare Company Shares by Retail Value 2001-2005
  • Table 7 Otc Healthcare Brand Shares by Retail Value 2002-2005
  • Table 8 Bayer Plc: Shares of Otc Healthcare by Subsector by Retail Value 2001-2005
  • Table 9 The Boots Co Plc: Shares of Otc Healthcare by Subsector by Retail Value 2001-2005
  • Table 10 Glaxosmithkline Plc: Shares of Otc Healthcare by Subsector by Retail Value 2001-2005
  • Table 11 Johnson & Johnson Msd Ltd: Shares of Otc Healthcare by Subsector by Retail Value 2001-2005
  • Table 12 Novartis Pharmaceuticals UK Ltd: Shares of Otc Healthcare by Subsector by Retail Value 2001-2005
  • Table 13 Pfizer Consumer Healthcare Ltd: Shares of Otc Healthcare by Subsector by Retail Value 2001-2005
  • Table 14 Reckitt Benckiser Plc: Shares of Otc Healthcare by Subsector by Retail Value 2001-2005
  • Table 15 Roche Products Ltd: Shares of Otc Healthcare by Subsector by Retail Value 2001-2005
  • Table 16 Seven Seas Ltd: Shares of Otc Healthcare by Subsector by Retail Value 2001-2005
  • Table 17 Ssl International Plc: Shares of Otc Healthcare by Subsector by Retail Value 2001-2005
  • Table 18 Wyeth Consumer Healthcare: Shares of Otc Healthcare by Subsector by Retail Value 2001-2005
  • Table 19 Sales of Otc Healthcare by Distribution Format: % Analysis 2000/2005
  • Table 20 Sales of Otc Healthcare by Sector and Distribution Format: % Analysis 2005
  • Table 21 Penetration of Private Label by Sector 2001-2005
  • Table 22 Forecast Sales of Otc Healthcare by Sector: Value 2005-2010
  • Table 23 Forecast Sales of Otc Healthcare by Sector: % Value Growth 2005-2010
  • Table 24 Sales of Wound Treatments by Subsector: Value 2000-2005
  • Table 25 Sales of Wound Treatments by Subsector: % Value Growth 2000-2005
  • Table 26 Wound Treatments Company Shares by Retail Value 2001-2005
  • Table 27 Wound Treatments Brand Shares by Retail Value 2002-2005
  • Table 28 Forecast Sales of Wound Treatments by Subsector: Value 2005-2010
  • Table 29 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2005-2010